Exocure Therapeutics
A novel exosomal cancer treatment
Startup Pre-Funding Israel Est. 2025
Total Raised
Undisclosed
Pre-Funding
Last Round
Undisclosed
Team
0
Confidence
37/100
About
ExoCure Therapeutics develops exosome-based cancer therapeutics designed to selectively target tumor pathways while reducing harm to healthy cells.
Details
Product Stage
R&D
Founded
2025
Registrar
517213088
Locations
9 Al-Rihana, Sakhnin, Israel
אלריחאנה, Sakhnin, 3081000, Israel
Links
Admin
Last Update
Mar 15, 2026
Missing
sector, number of employees, tags, invite member, business model, logo, description, video or image, funding rounds, news, markets, external profiles, not claimed
Internal
Created by
Ofir Muchnik (ofirm@sncentral.org)
Created
2026-03-15T00:00:00.000Z